Company & Sponsor Intelligence
Avid Radiopharmaceuticals
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials2
Recruiting0
Completed2
Countries1
Therapeutic footprint
alzheimersunclassified
Indexed studies
NCT00857506Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)
alzheimers · United StatesPHASE2
alzheimers · United StatesPHASE2
NCT0251604618F-AV-1451 Autopsy Study
unclassified · United StatesPHASE3
unclassified · United StatesPHASE3
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →